Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes
United European Gastroenterology Journal · 2024
DOI: 10.1002/ueg2.12515 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Rirong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Remission Induction, C-Reactive Protein, Colonoscopy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology.
Abstract (Originalsprache)
Background
Clinical remission (CR) is the principal short‐term treatment target in patients with ulcerative colitis (UC). However, whether rapidly achieving CR indicates better outcomes remains unclear.
Objectives
We aimed to explore the associations between the timing of CR and therapeutic outcomes in UC.
Methods
This study included UC patients from the UNIFI trial. Week‐2 CR and time to CR were the major variables of interest. Endoscopic remission (ER) at week 52 was the primary outcome. Multivariate logistic regression was performed to evaluate the association between variables and outcomes.
Results
Week‐2 CR was associated with ER (aOR: 2.37 [95% CI: 1.28, 4.37], p = 0.006) and Histological remission (HR) (aOR: 2.87 [95% CI: 1.42, 5.72], p = 0.003) at week 52. Moreover, C‐reactive protein (CRP) remission could further stratify patients without CR and predict week‐52 outcomes. Patients with clinical activity + CRP remission (aOR: 0.49 [95% CI: 0.26, 0.93], p = 0.039) and clinical activity + CRP activity (aOR: 0.24 [95% CI: 0.11, 0.52], p < 0.001) had gradually decreased likelihood of achieving ER, when compared to those with CR. For time to CR, we found that the earlier to CR, the better endoscopic and histological outcomes patients would attain. Patients achieving CR at weeks 2, 4/8, 12/16 and >16 had gradually reduced proportions of ER (51.9% vs. 40.8% vs. 31.6% vs. 8.8%, p < 0.001) and HR (37.0% vs. 19.8% vs. 17.1% vs. 6.1%, p < 0.001) at week 52. Compared with week 2, achieving CR at weeks 4/8, 12/16 and >16 had 39%, 55% and 92% lower likelihoods of week‐52 ER, respectively.
Conclusions
Week‐2 CR indicates better outcomes in UC patients receiving ustekinumab. Moreover, achieving CR more rapidly is associated with higher probability of ER and HR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Rirong Chen, Yizhe Tie, Minhu Chen, Li Li, Shenghong Zhang
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Department of Science and Technology
Zitieren
APA
Chen, R., Tie, Y., Huang, Y., Zhang, X., Zeng, Z., Chen, M., Li, L., & Zhang, S. (2024). Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12515
Vancouver
Chen R, Tie Y, Huang Y, Zhang X, Zeng Z, Chen M, et al. Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12515
BibTeX
@article{Chen2024,
author = {Chen, Rirong and Tie, Yizhe and Huang, Yongle and Zhang, Xi and Zeng, Zhirong and Chen, Minhu and Li, Li and Zhang, Shenghong},
title = {Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes},
journal = {United European Gastroenterology Journal},
year = {2024},
doi = {10.1002/ueg2.12515}
}
EUVIMED